Literature DB >> 22743370

β-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury.

Eric J Ley1, Morgan A Clond, Marko Bukur, Ryan Park, Michael Chervonski, Grant Dagliyan, Dan R Margulies, Patrick D Lyden, Peter S Conti, Ali Salim.   

Abstract

BACKGROUND: The purpose of this study was to evaluate how β-adrenergic receptor inhibition after traumatic brain injury (TBI) alters changes in early cerebral glucose metabolism and motor performance, as well as cerebral cytokine and heat shock protein (HSP) expression.
METHODS: Mouse cerebral glucose metabolism was measured by microPET fluorodeoxyglucose uptake and converted into standardized uptake values (SUV). Four groups of C57/Bl6 mice (wild type [WT]) were initially evaluated: sham or TBI, followed by tail vein injection of either saline or a nonselective β-adrenergic receptor inhibitor (propranolol, 4 mg/kg). Then motor performance, cerebral cytokine, and HSP70 expression were studied at 12 hours and 24 hours after sham injury or TBI in WT mice treated with saline or propranolol and in β1-adrenergic/β2-adrenergic receptor knockout (BARKO) mice treated with saline.
RESULTS: Cerebral glucose metabolism was significantly reduced after TBI (mean SUV TBI, 1.63 vs. sham 1.97, p < 0.01) and propranolol attenuated this reduction (mean SUV propranolol, 1.89 vs. saline 1.63, p < 0.01). Both propranolol and BARKO reduced motor deficits at 24 hours after injury, but only BARKO had an effect at 12 hours after injury. TBI WT mice treated with saline performed worse than propranolol mice at 24 hours after injury on rotarod (23 vs. 44 seconds, p < 0.01) and rearing (130 vs. 338 events, p = 0.01) results. At 24 hours after injury, sham BARKO and TBI BARKO mice were similar on rotarod (21 vs. 19 seconds, p = 0.53), ambulatory testing (2,891 vs. 2,274 events, p = 0.14), and rearing (129 vs. 64 events, p = 0.09) results. Interleukin 1β expression was affected by BARKO and propranolol after TBI; attenuation of interleukin 6 and increased HSP70 expression were noted only with BARKO.
CONCLUSION: β-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, as well as cerebral cytokine and HSP expression after TBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743370     DOI: 10.1097/TA.0b013e31825a769b

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  14 in total

1.  Sex differences in the regulation of brain IL-1β in response to chronic stress.

Authors:  David F Barnard; Kristin M Gabella; Adam C Kulp; Austin D Parker; Patrick B Dugan; John D Johnson
Journal:  Psychoneuroendocrinology       Date:  2019-01-25       Impact factor: 4.905

2.  Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial.

Authors:  Hosseinali Khalili; Rebecka Ahl; Shahram Paydar; Gabriel Sjolin; Yang Cao; Hossein Abdolrahimzadeh Fard; Amin Niakan; Kamil Hanna; Bellal Joseph; Shahin Mohseni
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

3.  Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality.

Authors:  Milap V Rakholia; Raj G Kumar; Byung-Mo Oh; Prerna R Ranganathan; Sarah L Berga; Patrick M Kochanek; Amy K Wagner
Journal:  J Neurotrauma       Date:  2018-08-24       Impact factor: 5.269

4.  (-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model.

Authors:  Yinyin Wu; Jing Cui
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-02-15       Impact factor: 3.000

Review 5.  Cerebral Microdialysis in Neurocritical Care.

Authors:  Ting Zhou; Atul Kalanuria
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-23       Impact factor: 5.081

Review 6.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

Review 7.  Beta blockers for acute traumatic brain injury: a systematic review and meta-analysis.

Authors:  Aziz S Alali; Victoria A McCredie; Eyal Golan; Prakesh S Shah; Avery B Nathens
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

8.  Thromboelastography After Murine TBI and Implications of Beta-Adrenergic Receptor Knockout.

Authors:  Douglas Z Liou; Ara Ko; Oksana Volod; Galinos Barmparas; Megan Y Harada; Matthew J Martin; Ali Salim; Navpreet Dhillon; Gretchen M Thomsen; Eric J Ley
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

9.  Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.

Authors:  Daniel J Kota; Karthik S Prabhakara; Alexandra J van Brummen; Supinder Bedi; Hasen Xue; Bryan DiCarlo; Charles S Cox; Scott D Olson
Journal:  Stem Cells Transl Med       Date:  2015-11-19       Impact factor: 6.940

Review 10.  TBI Rehabilomics Research: Conceptualizing a humoral triad for designing effective rehabilitation interventions.

Authors:  A K Wagner; R G Kumar
Journal:  Neuropharmacology       Date:  2018-09-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.